Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models
Douglas G. Farmer, Fady Kaldas, Dean Anselmo, Masamichi Katori, Xiu Da Shen, Charles Lassman, Marian Kaldas, Martine Clozel, Ronald W. Busuttil, Jerzy Kupiec-Weglinski
Dive into the research topics of 'Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models'. Together they form a unique fingerprint.